Palisade Bio (PALI) EPS (Diluted) (2016 - 2026)

Palisade Bio (PALI) EPS (Diluted) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.23
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.33
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.15
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.19
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Palisade Bio 372.94 Mn 247.74 Mn - -0.21

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.06
Mar 31, 2026 -0.05
Dec 31, 2025 -0.18
Sep 30, 2025 -0.38
Jun 30, 2025 -0.58
Mar 31, 2025 -0.47
Dec 31, 2024 -2.39
Sep 30, 2024 -2.32
Jun 30, 2024 -3.32
Mar 31, 2024 -4.59
Dec 31, 2023 -6.92
Sep 30, 2023 -7.76
Jun 30, 2023 -7.93
Mar 31, 2023 -8.13
Dec 31, 2022 -65.60
Sep 30, 2022 -69.21
Jun 30, 2022 -86.62
Mar 31, 2022 -181.71
Dec 31, 2021 -136.22
Sep 30, 2021 -188.44